APOTEX FDA Approval ANDA 206093

ANDA 206093

APOTEX

FDA Drug Application

Application #206093

Application Sponsors

ANDA 206093APOTEX

Marketing Status

Prescription001
Prescription002

Application Products

001TABLET;ORAL12.5MG0TETRABENAZINETETRABENAZINE
002TABLET;ORAL25MG0TETRABENAZINETETRABENAZINE

FDA Submissions

UNKNOWN; ORIG1AP2020-03-17STANDARD

Submissions Property Types

ORIG1Null31

TE Codes

001PrescriptionAB
002PrescriptionAB

CDER Filings

APOTEX
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 206093
            [companyName] => APOTEX
            [docInserts] => ["",""]
            [products] => [{"drugName":"TETRABENAZINE","activeIngredients":"TETRABENAZINE","strength":"12.5MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"TETRABENAZINE","activeIngredients":"TETRABENAZINE","strength":"25MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"03\/17\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-03-17
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.